Stock Events

Stock Events

Appili Therapeutics 

C$0.02
13
+C$0.01+33.33% Monday 19:55

Statistics

Day High
0.02
Day Low
0.02
52W High
0.04
52W Low
0.01
Volume
-
Avg. Volume
-
Mkt Cap
2.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

1JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.01
-0
-0
-0
Expected EPS
N/A
Actual EPS
N/A

Financials

-2,624%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
200,000Revenue
-5.25MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APLI.TO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap161.85B
Gilead Sciences is a biopharmaceutical company that competes with Appili Therapeutics in the development of antiviral drugs, including treatments for infectious diseases.
Merck
MRK
Mkt Cap276.38B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines for infectious diseases, directly competing with Appili Therapeutics' focus areas.
Pfizer
PFE
Mkt Cap153.59B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including treatments for infectious diseases, making it a competitor.
Abbvie
ABBV
Mkt Cap351.47B
AbbVie Inc. engages in the research and development of pharmaceutical products, including therapies for infectious diseases, competing with Appili's product pipeline.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson, through its pharmaceutical segment, develops treatments for infectious diseases, competing with Appili Therapeutics in this space.
Bristol-Myers Squibb
BMY
Mkt Cap119.87B
Bristol-Myers Squibb Company offers prescription pharmaceuticals in several therapeutic areas, including infectious diseases, making it a competitor to Appili Therapeutics.
Astrazeneca
AZN
Mkt Cap294.17B
AstraZeneca PLC is a biopharmaceutical company that develops and commercializes medicines for various diseases, including infections, competing with Appili Therapeutics.
Novartis
NVS
Mkt Cap280.79B
Novartis AG focuses on the discovery, development, and marketing of healthcare products, including treatments for infectious diseases, making it a competitor.
Sanofi
SNY
Mkt Cap112.08B
Sanofi is a healthcare company that develops and markets drugs with a focus on infectious diseases, directly competing with Appili Therapeutics.
GSK
GSK
Mkt Cap108.66B
GlaxoSmithKline plc is a global healthcare company that researches and develops pharmaceuticals, vaccines, and healthcare products, including for infectious diseases, competing with Appili Therapeutics.

About

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Show more...
CEO
Dr. Donald D. Cilla Jr., M.B.A., Pharmd
Employees
7
Country
Canada
ISIN
CA03783R1073

Listings

TO
CA
APLI.TO
OTC Link
US
APLIF

0 Comments

Share your thoughts

FAQ

What is Appili Therapeutics stock price today?▼
The current price of APLI.TO is C$0.02 CAD — it has increased by +33.33% in the past 24 hours. Watch Appili Therapeutics stock price performance more closely on the chart.
What is Appili Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Appili Therapeutics stocks are traded under the ticker APLI.TO.
Is Appili Therapeutics stock price growing?▼
APLI.TO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Appili Therapeutics has showed a -33.33% decrease.
What is Appili Therapeutics market cap?▼
Today Appili Therapeutics has the market capitalization of 2.57M
When is the next Appili Therapeutics earnings date?▼
Appili Therapeutics is going to release the next earnings report on July 01, 2026.
What is Appili Therapeutics revenue for the last year?▼
Appili Therapeutics revenue for the last year amounts to 200,000 CAD.
What is Appili Therapeutics net income for the last year?▼
APLI.TO net income for the last year is -5.25M CAD.
How many employees does Appili Therapeutics have?▼
As of April 29, 2026, the company has 7 employees.
In which sector is Appili Therapeutics located?▼
Appili Therapeutics operates in the Health & Wellness sector.
When did Appili Therapeutics complete a stock split?▼
Appili Therapeutics has not had any recent stock splits.
Where is Appili Therapeutics headquartered?▼
Appili Therapeutics is headquartered in Halifax, Canada.